Toggle navigation
Home
Search
Services
Blog
Contact
About
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
FOR MOMS:Culturally Relevant Treatment for Perinatal Depression
Comprehensive Collection, Charting, and Communication System
Cell Death in Embryonic Head Muscles
Halogenated Biogenic Amines in Biochemistry and Pharmacology
Granulosa Cell-Control of Na+/H+ Antiport and K+ Channel
Recently added grants:
CNS in Congenital DM1: Pathogenesis and Therapeutic Opportunities
Regulation of hippocampal morphogenesis and homeostasis by the E3 ubiquitin ligase CRL5
Leadership Administrative Core
Career Enhancement Core
Resource Support Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025011-000
Application #
6688657
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
A Phase Iib Cancer Prevention Trial of Nsaids in Oral Leukoplakia - Ws -261025011
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant